EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Genetic variation of the HIV-1 subtype C transmitted/founder viruses long terminal repeat elements and the impact on transcription activation potential and clinical disease outcomes

Paradise Madlala iD, Zakithi Mkhize, Shamara Naicker, Samukelisiwe P Khathi, Shreyal Maikoo, Kasmira Gopee, Krista L Dong, Thumbi Ndung'u

PLOS Pathogens · 12.06.2023 · 19 (6) · e1011194

DOI: 10.1371/journal.ppat.1011194 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS Pathogens, online erschienen am 12.06.2023. Verfasst von Paradise Madlala und 7 weiteren Autor:innen. Beteiligte Einrichtung: HIV Pathogenesis Programme, The Doris Duke Medical Research Institute, Nelson R. Mandela School of Medicine, University of KwaZulu-Natal, Durban, Sou…. Hauptthemen laut MEDLINE: HIV-1, HIV Infections. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 63 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Wellcome Trust, South African Medical Research Council, National Research Foundation Thuthuka Funding Instrument.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

A genetic bottleneck is a hallmark of HIV-1 transmission such that only very few viral strains, termed transmitted/founder (T/F) variants establish infection in a newly infected host. Phenotypic characteristics of these variants may determine the subsequent course of disease. The HIV-1 5’ long terminal repeat (LTR) promoter drives viral gene transcription and is genetically identical to the 3’ LTR. We hypothesized that HIV-1 subtype C (HIV-1C) T/F virus LTR genetic variation is a determinant of transcriptional activation potential and clinical disease outcome. The 3’LTR was amplified from plasma samples of 41 study participants acutely infected with HIV-1C (Fiebig stages I and V/VI). Paired longitudinal samples were also available at one year post-infection for 31 of the 41 participants. 3’ LTR amplicons were cloned into a pGL3-basic luciferase expression vector, and transfected alone or together with Transactivator of transcription ( tat ) into Jurkat cells in the absence or presence of cell activators (TNF- α , PMA, Prostratin and SAHA). Inter-patient T/F LTR sequence diversity was 5.7% (Renge: 2–12) with subsequent intrahost viral evolution observed in 48.4% of the participants analyzed at 12 months post-infection. T/F LTR variants exhibited differential basal transcriptional activity, with significantly higher Tat-mediated transcriptional activity compared to basal (p

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HIV-1HIV InfectionsHumansTranscriptional ActivationTranscription, Genetictat Gene Products, Human Immunodeficiency VirusTumor Necrosis Factor-alphaHIV Long Terminal RepeatGenetic VariationGene Expression Regulation, ViralPhorbol Esters

Substanzen

tat Gene Products, Human Immunodeficiency VirusTumor Necrosis Factor-alphaprostratinPhorbol Esters

Autor:innen und Institutionen

  • HIV Pathogenesis Programme, The Doris Duke Medical Research Institute, Nelson R. Mandela School of Medicine, University of KwaZulu-Natal, Durban, South Africa.
  • School of Laboratory Medicine and Medical Sciences, University of KwaZulu-Natal, Durban, South Africa.
  • Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology, and Harvard University, Cambridge, Massachusetts, United States of America.
  • Division of Infectious Diseases, Massachusetts General Hospital, Boston, Massachusetts, United States of America.
  • Harvard Medical School, Boston, Massachusetts, United States of America.
  • Africa Health Research Institute (AHRI), Durban, South Africa.

ORCID-Profile: Paradise Madlala

Förderung

  • Wellcome Trust
  • South African Medical Research Council
  • National Research Foundation Thuthuka Funding Instrument
  • Bill and Melinda Gates Foundation
  • International AIDS Vaccine Initiative
  • South African Research Chairs Initiative
  • Sub-Saharan African Network for TB/HIV Research Excellence (SANTHE), a DELTAS Africa Initiative
  • The Developing Excellence in Leadership, Training and Science in Africa (DELTAS Africa) programme - supported by the Wellcome Trust and the UK Foreign, Commonw…

Zitieren

APA

Madlala, P., Mkhize, Z., Naicker, S., Khathi, S. P., Maikoo, S., Gopee, K., Dong, K. L., & Ndung'u, T. (2023). Genetic variation of the HIV-1 subtype C transmitted/founder viruses long terminal repeat elements and the impact on transcription activation potential and clinical disease outcomes. PLOS Pathogens, 19(6), e1011194. https://doi.org/10.1371/journal.ppat.1011194

Vancouver

Madlala P, Mkhize Z, Naicker S, Khathi SP, Maikoo S, Gopee K, et al. Genetic variation of the HIV-1 subtype C transmitted/founder viruses long terminal repeat elements and the impact on transcription activation potential and clinical disease outcomes. PLOS Pathogens. 2023;19(6):e1011194. doi:10.1371/journal.ppat.1011194

BibTeX
@article{Madlala2023,
  author = {Madlala, Paradise and Mkhize, Zakithi and Naicker, Shamara and Khathi, Samukelisiwe P and Maikoo, Shreyal and Gopee, Kasmira and Dong, Krista L and Ndung'u, Thumbi},
  title = {Genetic variation of the HIV-1 subtype C transmitted/founder viruses long terminal repeat elements and the impact on transcription activation potential and clinical disease outcomes},
  journal = {PLOS Pathogens},
  year = {2023},
  volume = {19},
  number = {6},
  pages = {e1011194},
  doi = {10.1371/journal.ppat.1011194}
}
Kostenlos starten →